The Wyss Center and partners launch CHF 18 million Lighthouse Partnership to develop smarter therapies for neurologic and mental health disorders based on AI guided neuromodulation

The Wyss Center partners with the ALBA Network to raise awareness and advocate for increased equity, inclusion and visibility of scientists from underrepresented groups in brain research.

Gene therapy to boost rehabilitation success following spinal cord injury.

Project will push the boundaries of real-time brain-to-speech decoding with artificial intelligence algorithms and a miniaturized, wireless device.

The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives, has joined BioAlps, the life sciences cluster for Western Switzerland.

The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers

New research suggests that targeting proteins essential to neurotransmission could be a promising alternative to treat Alzheimer's disease

Neuro-sensing technology wins Silver prize following innovation and entrepreneurship accelerator.

Translational project will create the first detailed 3D maps of human glioblastomas with an integrated ‘tissue time machine’ to predict response to therapies.

Selected for outstanding innovation and potential for impact, the EPFL-based entrepreneurs will collaborate with the Wyss Center to accelerate commercialization of their technologies.

The new device will interact with the nerves responsible for constriction of brain arteries - a common complication after hemorrhagic stroke.